DK0662835T3 - Nye farmaceutiske præparater af spiramycin - Google Patents

Nye farmaceutiske præparater af spiramycin

Info

Publication number
DK0662835T3
DK0662835T3 DK93920939.1T DK93920939T DK0662835T3 DK 0662835 T3 DK0662835 T3 DK 0662835T3 DK 93920939 T DK93920939 T DK 93920939T DK 0662835 T3 DK0662835 T3 DK 0662835T3
Authority
DK
Denmark
Prior art keywords
spiramycin
pharmaceutical preparations
new pharmaceutical
formulations
new
Prior art date
Application number
DK93920939.1T
Other languages
English (en)
Inventor
Francois-Xavier Piot
Robert Rona
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Application granted granted Critical
Publication of DK0662835T3 publication Critical patent/DK0662835T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK93920939.1T 1992-10-05 1993-09-28 Nye farmaceutiske præparater af spiramycin DK0662835T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9211747A FR2696346B1 (fr) 1992-10-05 1992-10-05 Nouvelles formulations pharmaceutiques de spiramycine.
US08/470,319 US5696095A (en) 1992-10-05 1995-06-06 Pharmaceutical formulations of spiramycin

Publications (1)

Publication Number Publication Date
DK0662835T3 true DK0662835T3 (da) 1996-12-16

Family

ID=26229777

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93920939.1T DK0662835T3 (da) 1992-10-05 1993-09-28 Nye farmaceutiske præparater af spiramycin

Country Status (13)

Country Link
US (1) US5696095A (da)
EP (1) EP0662835B1 (da)
JP (1) JPH08501785A (da)
AT (1) ATE145555T1 (da)
CA (1) CA2146251A1 (da)
DE (1) DE69306263T2 (da)
DK (1) DK0662835T3 (da)
ES (1) ES2094566T3 (da)
FI (1) FI951594A0 (da)
FR (1) FR2696346B1 (da)
GR (1) GR3021788T3 (da)
HU (1) HU214825B (da)
WO (1) WO1994007504A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2793690B1 (fr) * 1999-03-30 2003-01-03 Cll Pharma Formulations pharmaceutiques en macrolides seuls ou associes a d'autres principes actifs et leur utilisation en therapeutique
FR2817751A1 (fr) * 2000-12-07 2002-06-14 Maximun Frederic Yanze Nouvelles compositions pharmaceutiques de sirops et sirops secs contenant de la quinine
EP2201939A1 (en) 2008-12-25 2010-06-30 Zentiva Kimyasal Ürünler Sanayi ve Ticaret A.S. Method for producing coated spiramycin and novel formulations containing the same
EP3346986A1 (en) 2015-09-11 2018-07-18 Andrew Guise An oral particulate composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375468A (en) * 1981-07-13 1983-03-01 Verex Laboratories, Inc. Constant order release aspirin composition and method of treating arthritis
IT1229568B (it) * 1989-04-17 1991-09-04 Giuliani Spa Composizione farmaceutica per uso orale adatta all'impiego nel lavaggio gastro intestinale, in particolare per uso diagnostico, oppure come lassativo catartico.
ES2017559A6 (es) * 1989-10-04 1991-02-16 Rhone Poulenc Farma Sa Procedimiento para la formulacion de la espiramicina.
US5082653A (en) * 1990-10-31 1992-01-21 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and antibiotic
FR2669533B1 (fr) * 1990-11-26 1993-01-08 Rhone Poulenc Rorer Sa Procede de preparation de formulations de spiramycine et formulations orales de spiramycine.

Also Published As

Publication number Publication date
GR3021788T3 (en) 1997-02-28
WO1994007504A1 (fr) 1994-04-14
FI951594A (fi) 1995-04-04
FR2696346B1 (fr) 1994-11-25
EP0662835A1 (fr) 1995-07-19
ATE145555T1 (de) 1996-12-15
HUT71555A (en) 1995-12-28
HU214825B (hu) 1998-06-29
US5696095A (en) 1997-12-09
DE69306263T2 (de) 1997-04-17
DE69306263D1 (de) 1997-01-09
CA2146251A1 (fr) 1994-04-14
FI951594A0 (fi) 1995-04-04
FR2696346A1 (fr) 1994-04-08
EP0662835B1 (fr) 1996-11-27
ES2094566T3 (es) 1997-01-16
HU9500972D0 (en) 1995-06-28
JPH08501785A (ja) 1996-02-27

Similar Documents

Publication Publication Date Title
NO934146D0 (no) Nye derivater av tiopyranopyrrol, deres fremstilling og farmas!ytiske preparater inneholdende forbindelsene
ATE109145T1 (de) Heterozyklische acylaminothiazolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
PT1121144E (pt) Preparados de insulina concentrada estavel para administracao pulmonar
NO863061D0 (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
DK0449247T3 (da) Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme
DE59009074D1 (de) Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus.
ATE161836T1 (de) 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate
SE8804629D0 (sv) New therapeutically active compounds
ATE110071T1 (de) Pyridazinon-derivate und diese enthaltende pharmazeutische zubereitungen.
NO170155C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater
NO910213D0 (no) Fremgangsmaate for fremstilling av orale legemiddelformer av pimobendan.
MC2289A1 (fr) Composes heterocycliques
NO871044D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO164542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo(3,4-d)-pyrimidinderivater.
DK0662835T3 (da) Nye farmaceutiske præparater af spiramycin
KR890701087A (ko) 부스피론 및 그의 염의 경구 투여용 제제
DK623888A (da) 9a-allyl- og propargylderivater af 9-deoxo-9a-aza-9a-homoerythromycin a, farmaceutiske praeparater indeholdende disse og deres anvendelse til fremstilling af antibakterielle laegemidler
EP0261524A3 (de) Arzneimittelzubereitungen
DE60017938D1 (de) Arzneizusammensetzungen und herstellungsverfahren von ergotalkaloidhaltigen arzneizusammensetzungen mit verzögerter wirkstoffabgabe und verbesserter bioverfügbarkeit
NO910186D0 (no) Fremgangsmaate for fremstilling av et oralt inhalerbart, farmasoeytisk atropin-salbutamol-aerosolpreparat.
DK463189A (da) 1,4-dihydropyridin-derivater, farmaceutiske praeparater indeholdende disse og deres anvendelse til fremstilling af antiallergiske og antiinflammatoriske laegemidler
猪爪信夫 The open-ring analogs of benzodizepine sleep inducers
NO167511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater.
FI940717A0 (fi) Streptogramiinien puhdistetut muodot, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
FI823762A0 (fi) Pyridazinon-iminer och deras fysiologiskt godtagbara syraadditionssalter, foerfarande foer deras framstaellning och dessa foereningar innehaollande terapeutiska medel